About Stanford University Medical Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Stanford University Medical Center
During the past decade, Stanford University Medical Center conducted 449 clinical trials. In the 10-year time frame, 449 clinical trials started and 291 clinical trials were completed, i.e. on
average, 64.8% percent of trials that started reached the finish line to date. In the past 5 years, 192 clinical trials started and 149 clinical trials were completed. i.e. 77.6%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Stanford University Medical Center" #1 sponsor was "Stanford University" with 168 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 41 trials
sponsored, "Pfizer" with 25 trials sponsored, "Eastern Cooperative Oncology Group" with 20 trials sponsored and "Abbott Medical Devices"
with 20 trials sponsored. Other sponsors include 662 different institutions and
companies that sponsored additional 348 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Stanford University Medical Center"
#1 collaborator was "National Cancer Institute (NCI)" with 104 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 38 trials as a collaborator, "Stanford University" with 25 trials as a collaborator, "Blood and Marrow Transplant Clinical Trials Network" with 20 trials as a collaborator and "National Institute of Neurological Disorders and Stroke (NINDS)" with 18 trials as a collaborator. Other collaborators include 580 different institutions and companies that were
collaborators in the rest 320 trials.
Clinical Trials Conditions at Stanford University Medical Center
According to Clinical.Site data, the most researched conditions in "Stanford University Medical Center" are
"HIV Infections" (45 trials), "Lymphoma" (18 trials), "Breast Cancer" (17 trials), "Cystic Fibrosis" (15 trials) and "Coronary Artery Disease" (13 trials). Many other conditions were trialed in "Stanford University Medical Center" in a lesser frequency.
Clinical Trials Intervention Types at Stanford University Medical Center
Most popular intervention types in "Stanford University Medical Center" are "Drug" (572 trials), "Device" (163 trials), "Other" (88 trials), "Biological" (87 trials) and "Procedure" (76 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (109 trials), "Cyclophosphamide" (17 trials), "cyclophosphamide" (12 trials), "laboratory biomarker analysis" (11 trials) and "paclitaxel" (11 trials). Other intervention names were less common.
Clinical Trials Genders at Stanford University Medical Center
The vast majority of trials in "Stanford University Medical Center" are
852 trials for "All" genders, 57 trials for "Female" genders and 30 trials for "Male" genders.
Clinical Trials Status at Stanford University Medical Center
Currently, there are 225 active trials in "Stanford University Medical Center".
9 are not yet recruiting,
111 are recruiting,
89 are Active, not recruiting,
and 16 are Enrolling by invitation.
In total, there were 543 completed trials in Stanford University Medical Center,
9 suspended trials,
and 114 terminated clinical trials to date.
Out of the total trials that were conducted in Stanford University Medical Center, 105 "Phase 1"
clinical trials were conducted, 297 "Phase 2" clinical
trials and 225 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 39 trials, and there were
also 188 trials that are defined as “Not Applicable".
Departments of Stanford University Medical Center
Stanford University Medical Center has several departments that took part in Clinical trials: "Southbay Oncology Hematology Partners" - 11 trials